Implementation of an Inhaled Nitric Oxide Protocol Decreases Direct Cost Associated With Its Use

References

1. 1.↵
   1. Dobyns EL,
   2. Cornfield DN,
   3. Anas NG,
   4. Fortenberry JD,
   5. Tasker RC,
   6. Lynch A,
   7. et al

   . Multicenter randomized controlled trial of the effects of inhaled nitric oxide therapy on gas exchange in children with acute hypoxemic respiratory failure. J Pediatr 1999;134(4):406–412.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Taylor MB,
   2. Laussen PC

   . Fundamentals of management of acute postoperative pulmonary hypertension. Pediatr Crit Care Med 2010;11(2Suppl):S27–S29.

   OpenUrlPubMed
3. 3.↵
   1. Nichols DG

   1. Wratney AT,
   2. Hamel DS,
   3. Cheifetz IM

   . Inhaled gases. In: Nichols DG , editor. Roger's textbook of pediatric intensive care, 4th edition. Philadelphia, PA: Lippincott Williams & Wilkins;2008:532-543.
4. 4.↵
   1. Cornfield DN

   . Acute respiratory distress syndrome in children: physiology and management. Curr Opin Pediatr 2013;25(3):338–343.

   OpenUrlPubMed
5. 5.↵
   1. Nakajima W,
   2. Ishida A,
   3. Arai H,
   4. Takada G

   . Methaemoglobinaemia after inhalation of nitric oxide in infant with pulmonary hypertension. Lancet 1997;350(9083):1002–1003.

   OpenUrlPubMedWeb of Science
6. 6.↵
   1. George TN,
   2. Johnson KJ,
   3. Bates JN,
   4. Segar JL

   . The effect of inhaled nitric oxide therapy on bleeding time and platelet aggregation in neonates. J Pediatr 1998;132(4):731–734.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Pierce CM,
   2. Peters MJ,
   3. Cohen G,
   4. Goldman AP,
   5. Petros AJ

   . Cost of nitric oxide is exorbitant (letter). BMJ 2002;325(7359):336.

   OpenUrlFREE Full Text
8. 8.↵
   1. Barr FE,
   2. Macrae D

   . Inhaled nitric oxide and related therapies. Pediatr Crit Care Med 2010;11(2 Suppl):S30–S36.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Goldman AP,
   2. Haworth SG,
   3. Macrae DJ

   . Does inhaled nitric oxide suppress endogenous nitric oxide production? J Thorac Cardiovasc Surg 1996;112(2):541–542.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Buga GM,
    2. Griscavage JM,
    3. Rogers NE,
    4. Ignarro LJ

    . Negative feedback regulation of endothelial cell function by nitric oxide. Circ Res 1993;73(5):808–812.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Assreuy J,
    2. Cunha FQ,
    3. Liew FY,
    4. Moncada S

    . Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharmacol 1993;108(3):833–837.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Marelich GP,
    2. Murin S,
    3. Battistella F,
    4. Inciardi J,
    5. Vierra T,
    6. Roby M

    . Protocol weaning of mechanical ventilation in medical and surgical patients by respiratory care practitioners and nurses: effect on weaning time and incidence of ventilator-associated pneumonia. Chest 2000;118(2):459–467.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.
    1. Duan J,
    2. Tang X,
    3. Huang S,
    4. Jia J,
    5. Guo S

    . Protocol-directed versus physician-directed weaning from noninvasive ventilation: the impact in chronic obstructive pulmonary disease patients. J Trauma Acute Care Surg 2012;72(5):1271–1275.

    OpenUrlPubMed
14. 14.↵
    1. Horst HM,
    2. Mouro D,
    3. Hall-Jenssens RA,
    4. Pamukov N

    . Decrease in ventilation time with a standardized weaning process. Arch Surg 1998;133(5):483–488.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Micek ST,
    2. Roubinian N,
    3. Heuring T,
    4. Bode M,
    5. Williams J,
    6. Harrison C,
    7. et al

    . Before-after study of a standardized hospital order set for the management of septic shock. Crit Care Med 2006;34(11):2707–2713.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Kortgen A,
    2. Niederprüm P,
    3. Bauer M

    . Implementation of an evidence-based “standard operating procedure” and outcome in septic shock. Crit Care Med 2006;34(4):943–949.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Bizzaro M,
    2. Gross I,
    3. Barbosa F

    . Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease. Cochrane Database Syst Rev 2014;(7):CD005055.
18. 18.↵
    1. Russell IA,
    2. Zwass MS,
    3. Fineman JR,
    4. Balea M,
    5. Rouine-Rapp K,
    6. Brook M,
    7. et al

    . The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesth Analg 1998;87(1):46–51.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Fullerton DA,
    2. Jones SD,
    3. Jaggers J,
    4. Piedalue F,
    5. Grover FL,
    6. McIntyre RC Jr.

    . Effective control of pulmonary vascular resistance with inhaled nitric oxide after cardiac operation. J Thorac Cardiovasc Surg 1996;111(4):753–762.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    1. Clark RH,
    2. Kueser TJ,
    3. Walker MW,
    4. Southgate WM,
    5. Huckaby JL,
    6. Perez JA,
    7. et al

    . Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N Engl J Med 2000;342(7):469–474.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.↵
    1. Roberts JD Jr.,
    2. Fineman JR,
    3. Morin FC 3rd.,
    4. Shaul PW,
    5. Rimar S,
    6. Schreiber MD,
    7. et al

    . Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med 1997;336(9):605–610.

    OpenUrlCrossRefPubMedWeb of Science
22. 22.↵
    1. Kollef MH,
    2. Micek ST

    . Using protocols to improve patient outcomes in the intensive care unit: focus on mechanical ventilation and sepsis. Semin Respir Crit Care Med 2010;31(1):19–30.

    OpenUrlCrossRefPubMed